| |
| |
|
| Insider
Information: |
Parsey Merdad |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
109,098 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,328,917 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
109,098 |
|
|
| Total
Value |
$6,328,917 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Medical Officer |
2024-04-01 |
96,304 |
2020-08-15 |
0 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2023-07-18 |
12,794 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-04-01 |
4 |
AS |
$72.96 |
$145,920 |
D/D |
(2,000) |
96,304 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-03-10 |
4 |
D |
$75.12 |
$360,801 |
D/D |
(4,803) |
98,304 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,401 |
103,107 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-02-29 |
4 |
AS |
$72.74 |
$598,624 |
D/D |
(8,230) |
92,706 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-02-28 |
4 |
AS |
$73.18 |
$146,360 |
D/D |
(2,000) |
100,936 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
76,853 |
126,325 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-01-31 |
4 |
D |
$78.26 |
$1,855,466 |
D/D |
(23,709) |
102,616 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-12-10 |
4 |
D |
$79.02 |
$100,276 |
D/D |
(1,269) |
71,640 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
72,909 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-09-12 |
4 |
AS |
$76.99 |
$115,562 |
D/D |
(1,501) |
70,130 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-09-10 |
4 |
D |
$76.00 |
$97,128 |
D/D |
(1,278) |
71,631 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
72,909 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,677) |
0 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
8,677 |
8,677 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
4,117 |
12,794 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,677 |
|
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-06-13 |
4 |
AS |
$76.90 |
$114,197 |
D/D |
(1,485) |
29,402 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
32,181 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-06-10 |
4 |
D |
$78.12 |
$101,087 |
D/D |
(1,294) |
30,887 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-03-13 |
4 |
AS |
$78.99 |
$483,893 |
D/D |
(6,126) |
70,130 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-03-10 |
4 |
D |
$79.50 |
$423,576 |
D/D |
(5,328) |
76,256 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,454 |
81,584 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-03-01 |
4 |
AS |
$79.96 |
$1,038,225 |
D/D |
(12,984) |
70,130 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-02-15 |
4 |
A |
$56.38 |
$21,199 |
D/D |
376 |
83,114 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-01-24 |
4 |
D |
$84.02 |
$1,491,271 |
D/D |
(17,749) |
82,738 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
